| Hypoimmune anti-CD19 chimeric antigen receptor T cells provide lasting tumor control in fully immunocompetent allogeneic humanized mice X Hu, K Manner, R DeJesus, K White, C Gattis, P Ngo, C Bandoro, ... Nature Communications 14 (1), 2020, 2023 | 24 | 2023 |
| A (fire) cloud-based DNA methylation data preprocessing and quality control platform D Kangeyan, A Dunford, S Iyer, C Stewart, M Hanna, G Getz, MJ Aryee BMC bioinformatics 20, 1-5, 2019 | 10 | 2019 |
| Computational methods for single-cell data analysis GC Yuan Humana Press, 2019 | 8 | 2019 |
| Preprocessing and computational analysis of single-cell epigenomic datasets C Lareau, D Kangeyan, MJ Aryee Computational Methods for Single-Cell Data Analysis, 187-202, 2019 | 3 | 2019 |
| Single cell bisulfite sequencing defines epigenetic diversification in chronic lymphocytic leukemia DA Landau, K Clement, H Gu, E Biederstedt, D Kangeyan, S Hill, L Wang, ... Blood 128 (22), 1047, 2016 | 2 | 2016 |
| Development of a cross flow filtration device for human blood cell fractionation D Swargaloganathan 2014 40th Annual Northeast Bioengineering Conference (NEBEC), 1-3, 2014 | 2 | 2014 |
| Functional T Cell Assays Are Predictive of Pre-Clinical Potency to Generate Allogeneic, Hypoimmune CD19 CAR T Cells K Tundwal, A Johnson, B Granger, J Moreno, O Liang, P Beauchesne, ... Blood 140 (Supplement 1), 4524-4525, 2022 | | 2022 |
| Efficient and Specific Multi-Locus Editing of Allogeneic CAR T Cells for Hypoimmunity during Large Scale Manufacture Using Cas12b C Chaivorapol, P Beauchesne, R De Jesus, WE Dowdle, X Chen, ... Blood 140 (Supplement 1), 1606-1607, 2022 | | 2022 |
| Microsatellite instability error correction in cell-free DNA sequencing DS Kangeyan, S Zhang, S Katz, B Crain, J Lee, AG Mentzer, C Echegaray, ... Cancer Research 80 (16_Supplement), 839-839, 2020 | | 2020 |
| Methods for Analyzing Sparse Genetic and Epigenetic Data: Single Cells to Population Levels DS Kangeyan Harvard University, 2019 | | 2019 |
Martin J. AryeeAssociate Professor, Dept of Data Science, Dana Farber Cancer Institute & Dept of Pathology, HarvardVerified email at ds.dfci.harvard.edu
